SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041336
Filing Date
2023-08-10
Accepted
2023-08-10 16:14:58
Documents
72
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q scph-20230630.htm   iXBRL 10-Q 2394000
2 EX-31.1 scph-ex31_1.htm EX-31.1 17738
3 EX-31.2 scph-ex31_2.htm EX-31.2 17183
4 EX-32.1 scph-ex32_1.htm EX-32.1 14521
5 EX-32.2 scph-ex32_2.htm EX-32.2 13788
  Complete submission text file 0000950170-23-041336.txt   9817153

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT scph-20230630_def.xml EX-101.DEF 162624
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT scph-20230630_cal.xml EX-101.CAL 56090
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT scph-20230630.xsd EX-101.SCH 50645
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT scph-20230630_lab.xml EX-101.LAB 463055
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT scph-20230630_pre.xml EX-101.PRE 331002
66 EXTRACTED XBRL INSTANCE DOCUMENT scph-20230630_htm.xml XML 2161867
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38293 | Film No.: 231159557
SIC: 2834 Pharmaceutical Preparations